Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors’ Rehabilitation Evaluation after CANcer (SURECAN) trial

actpapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This study protocol outlines a pragmatic randomized controlled trial evaluating an enhanced Acceptance and Commitment Therapy (ACT+) intervention for cancer survivors with low quality of life. The research compares the effectiveness and cost-effectiveness of ACT+ combined with usual aftercare against usual aftercare alone, targeting patients who have completed curative treatment. The primary outcome measures quality of life at 52 weeks among 344 participants recruited from secondary care sites.

ID
d7fec2762ed74e9c
Source org
PubMed Central
Author
Imran Khan (Queen Mary University of London), Stephanie Taylor (Queen Mary University of London), Clare Robinson (Queen Mary University of London), Elisavet Moschopoulou (Queen Mary University of London), Paul McCrone (University of Greenwich), Liam Bourke (Sheffield Hallam University), Mohamed A. Thaha (Queen Mary University of London), Kamaldeep Bhui (University of Oxford), Derek J. Rosario (University of Sheffield), Damien Ridge (University of Westminster), Sheila Donovan (Queen Mary University of London), Ania Korszun (Queen Mary University of London), Paul Little (University of Southampton), Adrienne Morgan, Olivier Quentin (Queen Mary University of London), Rebecca Roylance (University College London Hospitals NHS Foundation Trust), Peter D. White (University of Sheffield), Trudie Chalder (King's College London)
Published
2024-04-02
OA status
gold
DOI
10.1186/s13063-024-08062-4
PMID
Not recorded
PMCID
Not recorded
Citations
3

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:d7fec2762ed74e9c,
  title = {Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors’ Rehabilitation Evaluation after CANcer (SURECAN) trial},
  author = {Imran Khan and Stephanie Taylor and Clare Robinson and Elisavet Moschopoulou and Paul McCrone and Liam Bourke and Mohamed A. Thaha and Kamaldeep Bhui and Derek J. Rosario and Damien Ridge and Sheila Donovan and Ania Korszun and Paul Little and Adrienne Morgan and Olivier Quentin and Rebecca Roylance and Peter D. White and Trudie Chalder},
  year = {2024},
  journal = {PubMed Central},
  doi = {10.1186/s13063-024-08062-4},
  url = {https://doi.org/10.1186/s13063-024-08062-4}
}

RIS

TY  - JOUR
TI  - Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors’ Rehabilitation Evaluation after CANcer (SURECAN) trial
AU  - Khan, Imran
AU  - Taylor, Stephanie
AU  - Robinson, Clare
AU  - Moschopoulou, Elisavet
AU  - McCrone, Paul
AU  - Bourke, Liam
AU  - Thaha, Mohamed A.
AU  - Bhui, Kamaldeep
AU  - Rosario, Derek J.
AU  - Ridge, Damien
AU  - Donovan, Sheila
AU  - Korszun, Ania
AU  - Little, Paul
AU  - Morgan, Adrienne
AU  - Quentin, Olivier
AU  - Roylance, Rebecca
AU  - White, Peter D.
AU  - Chalder, Trudie
PY  - 2024
PB  - PubMed Central
DO  - 10.1186/s13063-024-08062-4
UR  - https://doi.org/10.1186/s13063-024-08062-4
ER  -

APA

Khan, I., Taylor, S., Robinson, C., Moschopoulou, E., McCrone, P., Bourke, L., Thaha, M. A., Bhui, K., Rosario, D. J., Ridge, D., Donovan, S., Korszun, A., Little, P., Morgan, A., Quentin, O., Roylance, R., White, P. D., & Chalder, T. (2024). Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors’ Rehabilitation Evaluation after CANcer (SURECAN) trial. PubMed Central. https://doi.org/10.1186/s13063-024-08062-4

Related entries

More like this